We are analyzing https://link.springer.com/article/10.1007/s12033-024-01134-5.

Title:
WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner | Molecular Biotechnology
Description:
N6-methyladenosine (m6A) is a common posttranscriptional RNA modification and plays an important role in cancer biology. Circular RNAs (circRNAs) are also reported to participate in lung adenocarcinoma (LUAD) progression. Here, we aimed to investigate the functions of Wilms tumor 1-associating protein (WTAP) methyltransferase and circEEF2 in LUAD cell tumorigenesis, and probe whether circEEF2 functioned through WTAP-induced m6A modification and its potential mechanisms. Functional analyses were conducted by tube formation, sphere formation, 5-ethynyl-2′-deoxyuridine (EdU), flow cytometry, and transwell assays in vitro as well as tumor formation experiments in mice, respectively. The N6-methyladenine (m6A) modification in circEEF2 mRNA was determined by RNA immunoprecipitation (Me-RIP) assay. The interaction between IGF2BP2 (Insulin Like Growth Factor 2 MRNA-Binding Protein 2) and circEEF2 or Calcium-activated nucleotidase 1 (CANT1) mRNA was confirmed using RIP assay. LUAD tissues and cells showed high circEEF2 expression, and the deficiency of circEEF2 suppressed LUAD cell angiogenesis, stemness, proliferation, migration, and invasion. WTAP induced circEEF2 m6A modification. WTAP silencing repressed the oncogenic phenotypes of LUAD cells via stabilizing circEEF2 in an m6A-dependent manner. IGF2BP2 interacted with circEEF2 and CANT1, and WTAP and circEEF2 could regulate CANT1 expression through IGF2BP2. The inhibition of LUAD cell oncogenic phenotypes caused by circEEF2 deficiency was abolished by CANT1 overexpression. In addition, WTAP silencing impeded LUAD growth via modulating circEEF2 and CANT1 in vivo. WTAP-mediated m6A modification of circEEF2 promotes lung adenocarcinoma growth and tumorigenesis by stabilizing CANT1 through IGF2BP2.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, article, google, scholar, cas, central, cancer, cell, lung, wang, circeef, adenocarcinoma, liu, zhang, chen, modification, molecular, promotes, rna, progression, wtap, luad, yang, journal, research, igfbp, data, zheng, nmethyladenosine, potential, growth, cells, access, pathway, shi, zhao, death, disease, nature, privacy, cookies, content, wtapmediated, tumorigenesis, stabilizing, circular, expression, signaling, author, medicine,

Topics {✒️}

wtap-mediated n6-methyladenine modification microrna-320b/hoxa10/tgfβ2 pathway month download article/chapter m6a-hur-dependent epigenetic silencing mir-5580-5p/fgb axis wtap-mediated m6a modification wtap-induced m6a modification matrix stiffness-mediated effects targeting circular rnas mir-29b-3p attenuates writing—original draft preparation wtap-dependent m6a methylation lncrna diaph1-as1 enhances promote pdl1/pd1 expression erk/mapk signalling pathway potential therapeutic target m6a-dependent ferroptosis regulation gene expression regulation rna n6-methyladenosine methyltransferase mir-1322/cant1 axis calcium-activated nucleotidase 1 related subjects full article pdf wtap facilitates progression m6a-dependent manner igf2bp2-dependent manner wtap silencing repressed mettl3 promotes glycolysis calcium-activated nucleotides 1 rna n6-methyladenosine promotes cell proliferation privacy choices/manage cookies potential prognostic factor luad cell tumorigenesis n6-methyladenine signaling pathway facilitates lung cancer progression tumor-biologically relevant xiaoping cai stemness characteristics occurring biophysical research communications regulate cant1 expression sponging mir-433-3p m6a-mediated upregulation nature reviews immunology tumor formation experiments bmc pulmonary medicine egfr/erk pathway nature cell biology holds exclusive rights

Schema {🗺️}

WebPage:
      mainEntity:
         headline:WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner
         description:N6-methyladenosine (m6A) is a common posttranscriptional RNA modification and plays an important role in cancer biology. Circular RNAs (circRNAs) are also reported to participate in lung adenocarcinoma (LUAD) progression. Here, we aimed to investigate the functions of Wilms tumor 1-associating protein (WTAP) methyltransferase and circEEF2 in LUAD cell tumorigenesis, and probe whether circEEF2 functioned through WTAP-induced m6A modification and its potential mechanisms. Functional analyses were conducted by tube formation, sphere formation, 5-ethynyl-2′-deoxyuridine (EdU), flow cytometry, and transwell assays in vitro as well as tumor formation experiments in mice, respectively. The N6-methyladenine (m6A) modification in circEEF2 mRNA was determined by RNA immunoprecipitation (Me-RIP) assay. The interaction between IGF2BP2 (Insulin Like Growth Factor 2 MRNA-Binding Protein 2) and circEEF2 or Calcium-activated nucleotidase 1 (CANT1) mRNA was confirmed using RIP assay. LUAD tissues and cells showed high circEEF2 expression, and the deficiency of circEEF2 suppressed LUAD cell angiogenesis, stemness, proliferation, migration, and invasion. WTAP induced circEEF2 m6A modification. WTAP silencing repressed the oncogenic phenotypes of LUAD cells via stabilizing circEEF2 in an m6A-dependent manner. IGF2BP2 interacted with circEEF2 and CANT1, and WTAP and circEEF2 could regulate CANT1 expression through IGF2BP2. The inhibition of LUAD cell oncogenic phenotypes caused by circEEF2 deficiency was abolished by CANT1 overexpression. In addition, WTAP silencing impeded LUAD growth via modulating circEEF2 and CANT1 in vivo. WTAP-mediated m6A modification of circEEF2 promotes lung adenocarcinoma growth and tumorigenesis by stabilizing CANT1 through IGF2BP2.
         datePublished:2024-04-15T00:00:00Z
         dateModified:2024-04-15T00:00:00Z
         pageStart:1494
         pageEnd:1508
         sameAs:https://doi.org/10.1007/s12033-024-01134-5
         keywords:
            LUAD
            m6A
            WTAP
            circEEF2
            IGF2BP2
            CANT1
            Stemness
            Biotechnology
            Biochemistry
            general
            Cell Biology
            Protein Science
            Biological Techniques
            Human Genetics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig7_HTML.png
         isPartOf:
            name:Molecular Biotechnology
            issn:
               1559-0305
               1073-6085
            volumeNumber:67
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hao Zheng
               affiliation:
                     name:Lishui People’s Hospital
                     address:
                        name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhuo Cao
               affiliation:
                     name:Lishui People’s Hospital
                     address:
                        name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuankai Lv
               affiliation:
                     name:Lishui People’s Hospital
                     address:
                        name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoping Cai
               url:http://orcid.org/0009-0000-3695-6723
               affiliation:
                     name:Lishui People’s Hospital
                     address:
                        name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner
      description:N6-methyladenosine (m6A) is a common posttranscriptional RNA modification and plays an important role in cancer biology. Circular RNAs (circRNAs) are also reported to participate in lung adenocarcinoma (LUAD) progression. Here, we aimed to investigate the functions of Wilms tumor 1-associating protein (WTAP) methyltransferase and circEEF2 in LUAD cell tumorigenesis, and probe whether circEEF2 functioned through WTAP-induced m6A modification and its potential mechanisms. Functional analyses were conducted by tube formation, sphere formation, 5-ethynyl-2′-deoxyuridine (EdU), flow cytometry, and transwell assays in vitro as well as tumor formation experiments in mice, respectively. The N6-methyladenine (m6A) modification in circEEF2 mRNA was determined by RNA immunoprecipitation (Me-RIP) assay. The interaction between IGF2BP2 (Insulin Like Growth Factor 2 MRNA-Binding Protein 2) and circEEF2 or Calcium-activated nucleotidase 1 (CANT1) mRNA was confirmed using RIP assay. LUAD tissues and cells showed high circEEF2 expression, and the deficiency of circEEF2 suppressed LUAD cell angiogenesis, stemness, proliferation, migration, and invasion. WTAP induced circEEF2 m6A modification. WTAP silencing repressed the oncogenic phenotypes of LUAD cells via stabilizing circEEF2 in an m6A-dependent manner. IGF2BP2 interacted with circEEF2 and CANT1, and WTAP and circEEF2 could regulate CANT1 expression through IGF2BP2. The inhibition of LUAD cell oncogenic phenotypes caused by circEEF2 deficiency was abolished by CANT1 overexpression. In addition, WTAP silencing impeded LUAD growth via modulating circEEF2 and CANT1 in vivo. WTAP-mediated m6A modification of circEEF2 promotes lung adenocarcinoma growth and tumorigenesis by stabilizing CANT1 through IGF2BP2.
      datePublished:2024-04-15T00:00:00Z
      dateModified:2024-04-15T00:00:00Z
      pageStart:1494
      pageEnd:1508
      sameAs:https://doi.org/10.1007/s12033-024-01134-5
      keywords:
         LUAD
         m6A
         WTAP
         circEEF2
         IGF2BP2
         CANT1
         Stemness
         Biotechnology
         Biochemistry
         general
         Cell Biology
         Protein Science
         Biological Techniques
         Human Genetics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12033-024-01134-5/MediaObjects/12033_2024_1134_Fig7_HTML.png
      isPartOf:
         name:Molecular Biotechnology
         issn:
            1559-0305
            1073-6085
         volumeNumber:67
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hao Zheng
            affiliation:
                  name:Lishui People’s Hospital
                  address:
                     name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhuo Cao
            affiliation:
                  name:Lishui People’s Hospital
                  address:
                     name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuankai Lv
            affiliation:
                  name:Lishui People’s Hospital
                  address:
                     name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoping Cai
            url:http://orcid.org/0009-0000-3695-6723
            affiliation:
                  name:Lishui People’s Hospital
                  address:
                     name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Biotechnology
      issn:
         1559-0305
         1073-6085
      volumeNumber:67
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lishui People’s Hospital
      address:
         name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
         type:PostalAddress
      name:Lishui People’s Hospital
      address:
         name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
         type:PostalAddress
      name:Lishui People’s Hospital
      address:
         name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
         type:PostalAddress
      name:Lishui People’s Hospital
      address:
         name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hao Zheng
      affiliation:
            name:Lishui People’s Hospital
            address:
               name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
               type:PostalAddress
            type:Organization
      name:Zhuo Cao
      affiliation:
            name:Lishui People’s Hospital
            address:
               name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
               type:PostalAddress
            type:Organization
      name:Yuankai Lv
      affiliation:
            name:Lishui People’s Hospital
            address:
               name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
               type:PostalAddress
            type:Organization
      name:Xiaoping Cai
      url:http://orcid.org/0009-0000-3695-6723
      affiliation:
            name:Lishui People’s Hospital
            address:
               name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
      name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
      name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
      name:Department of Respiratory and Critical Care Medicine, Lishui People’s Hospital, Lishui City, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(166)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.42s.

LINK . SPRINGER . COM {}